Media Center
Company News
current location:Home >> Media Center >> Company News
Asymchem attends JPM Healthcare Conference
2020-01-21 16:27

13-16 January 2020, San Francisco. Asymchem Laboratories Co., Ltd. was invited to attend the JP Morgan 38th Annual Healthcare Conference. The annual conference is the largest and most informative healthcare investment symposium in the industry. It brings together industry leaders, fast-emerging companies, innovative technology creators and members of the investment community to explore market trends and innovative solutions for the global healthcare landscape. The conference also acts as a platform for global investment opportunities ranging from start-up companies to those with high market cap.


屏幕快照 2020-04-04 下午4.28.27.png屏幕快照 2020-02-14 下午8.46.01.png


What is now known as the annual J.P. Morgan Healthcare Conference began in 1983 and was hosted by Hambrecht & Quist (H&Q). H&Q was acquired by Chase in 2000 and a year later Chase was acquired by J.P. Morgan. Many now well-known companies such as Genentech, Regeneron, and Gilead first garnered major visibility and attracted investments through the conference. At its infancy, the conference focused on the biotech industry and now encompass the entire healthcare landscape including biotech companies, pharmaceutical firms, medical device companies, and those in the field of information technology, artificial intelligence and big data in healthcare.


屏幕快照 2020-02-14 下午8.46.14.png

More than 9,000 attendees and over 450 companies, including thousands of investors and healthcare companies such as Roche and Pfizer attend the conference. They celebrate the previous year’s achievements and discuss new R&D strategies, future planning, cutting-edge technologies, M&As and future partnerships. 


屏幕快照 2020-02-14 下午8.46.24.png


A major focus of this year’s conference was the rising cost of drugs to consumers. Chris Schott, J.P. Morgan’s senior analyst, stated that the affordability of patients is a major challenge facing pharmaceutical companies and biotech firms. They should not just focus on drug discovery, but also guarantee patients affordable and accessible drugs.   


屏幕快照 2020-02-14 下午8.46.33.png


Asymchem has been making enormous efforts to provide innovative solutions to curve the rising cost of drugs. Green technologies such as flow chemistry and enzymatic catalysis developed by Asymchem have been successfully applied to pilot and commercial production. These innovations are widely acknowledged by global clients and investors. The development and implementation of these technologies have significantly reduced production cost, energy consumption and waste emission – improving our client base’s ability to providing effective and affordable drugs to all patients. In addition, Asymchem’ expansion into CMC and clinical research, provides high quality services for the entire lifecycle of drugs and shortens time-to-market periods.



Asymchem will continue to seek more opportunities to cooperate with global clients and develop new technologies to benefit global pharmaceutical companies and patients.


Last:
Postal Address
  • Asymchem Inc. 600 Airport Blvd PO Box 1310
  • Morrisville NC 27560 USA
Physical Address
  • Asymchem Inc.
  • 600 Airport Blvd., Suite 1000 Morrisville, NC 27560 USA
Contact Us
  • information@asymchem.com
  •  

Group official WeChat

Human resources WeChat